Delivery Order SPE2DB22D2007-SPE2DB26FH6JN
- Not listed
- The Defense Logistics Agency awarded a $3,007.12 delivery order to AmerisourceBergen Drug Corp for Zymfentra 120 mg/mL pen kits, with an ultimate completion date of September 25, 2025. This competitive delivery order represents a firm fixed price transaction with no set-aside designation. The award was made on September 4, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Zymfentra 120 mg/mL pens in a two-pack quantity, with a ceiling value of $1,503.56 and a firm fixed price structure. This is a non-set-aside competitive award with an ultimate completion date of October 7, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,007.12 to AmerisourceBergen Drug Corp for Zymfentra 120 mg/ml pen kits, with an ultimate completion date of October 7, 2025. This non-set-aside, firm fixed-price delivery order represents a competitive award under the company's existing indefinite delivery contract vehicle with DLA. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,007.12 to AmerisourceBergen Drug Corp for Zymfentra 120 mg/ml pen kits on September 19, 2025, with completion targeted for October 10, 2025. This firm fixed-price delivery order was awarded without a set-aside designation through open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement serving military...
- The Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $3,007.12 for Zymfentra 120 mg/ml pens (2-pack quantity) on August 1, 2025, with an ultimate completion date of August 22, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the place of performance location. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,503.56 to AmerisourceBergen Drug Corp for Zymfentra 120 mg/ml pen kits on August 5, 2025, with an ultimate completion date of August 26, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves...
- The Defense Logistics Agency awarded a delivery order valued at $1,503.56 to AmerisourceBergen Drug Corp for the supply of Zymfentra 120 mg/ml pen (2-pack units) on August 5, 2025, with an ultimate completion date of August 26, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- On September 22, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $6,014.24 to AmerisourceBergen Drug Corp for the supply of Zymfentra 120 mg/ml pens in a two-pack configuration. This firm fixed-price delivery order, with an ultimate completion date of October 14, 2025, represents a non-competitive award under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 15, 2025, for the supply of Zymfentra 120 mg/ml pen (2-pack) with a ceiling value of $1,503.56. This is a firm fixed price delivery order with no set-aside designation, utilizing competitive procurement procedures. The order is scheduled for ultimate completion by November 5, 2025, with performance to be completed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The...
- The Defense Logistics Agency awarded a $1,503.56 delivery order to AmerisourceBergen Drug Corp for Zymfentra 120 mg/ml pen (2-pack) with a completion date of September 30, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The award was issued on September 9, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB26FH6JNDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Zymfentra 120 mg/ml pen kits, with a contract ceiling value of $1,503.56. This is a firm fixed price delivery order with no set-aside designation, competitively awarded through open competition. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of November 7, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. AmerisourceBergen Drug Corp functions as a critical pharmaceutical distributor and healthcare solutions provider for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Health Agency and other government entities. The company's extensive portfolio of federal contracts encompasses a wide range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This specific delivery order for Zymfentra pen kits represents one of numerous small-value transactions the company fulfills through its comprehensive DLA contract vehicle, demonstrating the company's capability to supply specialized pharmaceutical products to support military healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 10/17/25 |